Hospital-acquired Infection Treatment Market Insights, Trends, Size and Growth Analysis 2022-2026

1
Hospital-acquired Infection Treatment Market
Insights, Trends, Size and Growth Analysis
2022-2026 Hospital-acquired infections can be
extremely distressing for patients who are
already ailing through an existing
condition. The growing use of surgical
equipment, or treatment aids, that are often
unsterilized has increased the incidence of
hospital-acquired infections. Treatment of these
infections is crucial to ensure that the
recovery cycle of patients doesnt get
disrupted. Nosocomial site infection is the
most common hospital-acquired infection that has
gained traction from the healthcare
fraternity. It is important to administer
pragmatic treatment lines to prevent or
alleviate the incidence of
healthcare-acquired infections (HAIs)
infections. In view of the aforementioned
factors, it is safe to state that the global
hospital-acquired infection treatment
market would tread along a lucrative
trajectory. The collective implications of
acquiring infections during surgery are
abysmal. Patients who acquire such
infections are five times more likely
to require readmission to hospitals post
discharge. Moreover, these patients spend,
on an average, 6.5 extra days in the hospital as
against a normal recovering patient. The
healthcare industry is taking cognizance of
these trends to assimilate treatment
frameworks that prioritize prevention of
infections. Several practices such as the use of
robotic surgery and treatment systems to reduce
HAIs could emerge across the healthcare industry
in the times to follow. Get a Sample Copy of
Hospital-acquired Infection Treatment Market
https//www.fairfieldmarketresearch.com/report/hos
pital-acquired-infection- treatment-market/request
-sample High Incidence of Urinary Tract
Infections to Bolster the Prospects of Market
Growth Several types of hospital-acquired
infections have irked healthcare professionals in
recent years. Some of these infections include
pneumonia, nosocomial infections, bloodstream
infections, and urinary tract infections. Amongst
these, the incidence of urinary tract infection
is estimated to be the highest amongst patients
of varying age groups. In the US, urinary
tract infections account for 32 of all
hospital- acquired infections. The rising costs
associated with treatment of such infections has
led the healthcare industry to rethink its
modes of treatment and disease
prevention. HAIs incur heavy expenditures
upon the healthcare industry, and
2
could be a source of turmoil within global
healthcare. It is, therefore, logical to
expect a rise in investments towards treating
hospital-acquired infections. Asia Pacific
Market Exhibits a Humongous Opportunity for
Market Growth and Expansion Several developing
countries in Asia Pacific are characterized by
poorly-managed primary healthcare units
(PHUs). Therefore, the incidence of hospital
acquired infections in the region is
alarmingly high. However, renewed efforts of
state bodies to rejuvenate the healthcare
setup in the region offers a commendable
opportunity for market growth and expansion. The
casualty count owing to HAIs is exceedingly high
across India. This factor is also necessitating
the use of effective treatment lines to alleviate
the impacts of hospital acquired infections. The
second wave of the COVID-19 pandemic almost
toppled the healthcare industry in India, and
necessitated the development of a robust
framework to prevent secondary infections.
This factor shall bode well for the growth of the
Asia Pacific hospital acquired infection
treatment market. Some of the prominent names in
the global hospital acquired infection treatment
market are Pfizer Inc., Merck Co., Inc., Bayer
AG, Daiichi Sankyo Company Limited,
AstraZeneca, GlaxoSmithKline Plc., AbbVie
Inc., Allergan Plc., F. Hoffmann-La Roche
Ltd, and Bristol-Myers Squibb. For More
Information Visit https//www.fairfieldmarketrese
arch.com/report/hospital-acquired-infection-
treatment-market About Us Fairfield Market
Research is a UK-based market research provider.
Fairfield offers a wide spectrum of services,
ranging from customized reports to
consulting solutions. With a strong European
footprint, Fairfield operates globally and helps
businesses navigate through business cycles,
with quick responses and multi- pronged
approaches. The company values an eye for
insightful take on global matters, ably backed
by a team of exceptionally experienced
researchers. With a strong repository of
syndicated market research reports that are
continuously published updated to ensure the
ever-changing needs of customers are met with
absolute promptness. Contact Fairfield Market
Research
London, UK
3
UK 44 (0)20 30025888 USA (Toll-free) 1 (844)
3829746 Web https//www.fairfieldmarketresearch.c
om Email sales_at_fairfieldmarketresearch.com
Follow Us LinkedIn